Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q2 2022 call → NOWe need answer YES or NO. Need analyze transcript. Question: Does management describe company as currently living through defined waiting period paying out of own pocket, cost now for benefit not arrived, end near-dated event visible. Need identify if management conveys all three. Transcript: Management discusses acquisitions Alliant, Zelman, GeoPhy added $18M personnel expense in Q2 '22 over Q2 '21, putting downward pressure on earnings, but "we love these investments. Alliant and Zelman are growing faster than pro forma, and GeoPhy has ability to transform..." Also GFI development team included in Capital Markets segment, increased personnel expense, not yet accretive to overall operating margins. "Although the acquisition of GFI is already being reflected in growth rates of small balance lending and appraisal businesses, the combination of those businesses is not yet accretive to our overall operating margins." Also GeoPhy dilution $0.30-$0.40 for this year, expected accretive 2023. Management says "we are not forecasting that until 2023 at this point." Is this a defined waiting period? They are paying now for acquisitions (personnel expense) with benefit not yet arrived? But Alliant and Zelman are growing faster, contributing revenue. GeoPhy and GFI not yet accretive. They expect to become accretive in 2023. Is that near-dated? Yes within roughly a year. Is it main current work? Management says "we have slowed down hiring... integrated acquisitions... using what we have today." They are not apologizing; they love investments. They are bearing cost. But is it "one coherent situation" with all three? Need be careful: The question asks "does management describe the company as CURRENTLY LIVING THROUGH A DEFINED WAITING PERIOD IT IS PAYING FOR OUT OF ITS OWN POCKET — that is, does management convey that the company is presently carrying real, ongoing cash or earnings cost for something whose benefit has not arrived yet, AND that the end of that waiting period is a specific, near-dated event the company can already see and is already working toward?" Management mentions acquisitions added $18M personnel expense in Q2 '22 over Q2 '21, downward pressure on earnings. They expect GeoPhy to become accretive in 2023. Also GFI not yet accretive.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.